Editors: Estela M. Novak, Eduardo M. Rego

Physiopathogenesis of Hematological Cancer

eBook: US $35 Special Offer (PDF + Printed Copy): US $148
Printed Copy: US $131
Library License: US $140
ISBN: 978-1-60805-588-3 (Print)
ISBN: 978-1-60805-259-2 (Online)
Year of Publication: 2012
DOI: 10.2174/97816080525921120101

Introduction

The number of new discoveries related to diagnostics and therapeutics of hematological cancer is significant. These have resulted in continuous progress in fundamental knowledge about molecular and cellular mechanisms in hematological neoplasia. Physiopathogenesis of Hematological Cancer presents a concise overview of the cellular and molecular biology of myelo- and Lymphoproliferative disorders. The expert reviews presented within this e-book are also accompanied by bibliographic references for relevant scientific literature. This book should prove to be a valuable reference tool for both medical graduate and postgraduates in the field of oncology.

Foreword

The annual incidence of hematological malignancies in Europe approaches 20 per 100000, making them the most common type of cancer in this continent and the world. The rapidly increased amount of new information generated in this field justifies their transference, in an organized form, to professionals who take care of these patients. This book has this purpose and approaches the subject of the hematological malignancies from a basic scientific standpoint and will be of great value to both clinicians and scientists working in this field. The first Section deals with the molecular and cellular biology of hematological tumors describing and discussing normal and leukemic hematopoeisis, cancer stem cells, apoptosis, epigenetics, microRNA, transcription factors, protein prenylation, and angiogenesis. The second Section discusses the molecular basis of lymphoid neoplasias with emphasis on lymphomas, multiple myeloma, and acute lymphoblastic leukemia. Section III on the the molecular pathogenesis of acute and chronic mieloproliferative disorders. Finally, Section IV presents the molecular basis of cancer therapy and future perspectives. All the contributors are experts in their fields and work in Brazil. The majority are affiliated to the University of São Paulo (USP) and University of Campinas (Unicamp).

Roberto Passetto Falcão
Professor in Hematology, Medical School of Ribeirão Preto
National Institute of Science and Technology in Stem Cell and Cell Therapy
University of São Paulo, Ribeirão Preto, SP
Brazil


RELATED BOOKS

.Topics in Anti-Cancer Research.
.Frontiers in Clinical Drug Research - Anti-Cancer Agents.
.Advances in Cancer Nanotheranostics for Experimental and Personalized Medicine.
.Current Advances in Breast Cancer Research: A Molecular Approach.